Statement of Retraction: The effect of zinc and vitamin E cosupplementation on metabolic status and its related gene expression in patients with gestational diabetes (The Journal of Maternal-Fetal & Neonatal Medicine, (2019), 32, 24, (4120-4127), 10.1080/14767058.2018.1481952);The effect of zinc and vitamin E cosupplementation on metabolic status and its related gene expression in patients with gestational diabetes

Journal of Maternal-Fetal and Neonatal Medicine

Volumn 32, Issue 24, 2019, Pages 4120-4127

  Ostadmohammadi, Vahidreza ^a   Samimi, Mansooreh ^a   Mobini, Moein ^b   Zarezade Mehrizi, Maryam ^a   Aghadavod, Esmat ^a   Chamani, Maryam ^c   Dastorani, Majid ^a   Asemi, Zatollah ^a  

^a KASHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b UNIVERSITY OF CALGARY   (Canada)

^c IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Gene expression; gestational diabetes; insulin; lipid; supplementation

Indexed keywords

ALPHA TOCOPHEROL; CHOLESTEROL; GLUCONATE ZINC; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN RECEPTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; ANTIOXIDANT; TRACE ELEMENT; ZINC;

ADULT; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; FEMALE; GENE EXPRESSION; GENE EXPRESSION REGULATION; HOMEOSTASIS MODEL ASSESSMENT; HUMAN; HUMAN CELL; INSULIN BLOOD LEVEL; INSULIN METABOLISM; INTERVENTION STUDY; LIPID METABOLISM; MAJOR CLINICAL STUDY; METABOLISM; PERIPHERAL BLOOD MONONUCLEAR CELL; PREGNANCY DIABETES MELLITUS; PRIORITY JOURNAL; QUANTITATIVE INSULIN SENSITIVITY CHECK INDEX; RANDOMIZED CONTROLLED TRIAL; VITAMIN SUPPLEMENTATION; DIETARY SUPPLEMENT; PREGNANCY;

ADULT; ANTIOXIDANTS; DIABETES, GESTATIONAL; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; FEMALE; GENE EXPRESSION; HUMANS; INSULIN; LIPID METABOLISM; PREGNANCY; TRACE ELEMENTS; VITAMIN E; ZINC;

EID: 85048465331     PISSN: 14767058     EISSN: 14764954     Source Type: Journal    
DOI: 10.1080/14767058.2024.2364983     Document Type: Erratum

References (43)

1. Kerner W, Brückel J, German Diabetes Association. Definition, classification and diagnosis of diabetes mellitus. Exp Clin Endocrinol Diabetes. 2014;122(7):384–386.
2. DeSisto CL, Kim SY, Sharma AJ. Prevalence estimates of gestational diabetes mellitus in the United States, Pregnancy Risk Assessment Monitoring System (PRAMS), 2007–2010. Prev Chronic Dis. 2014;11:E104.
3. Qiu C, Sorensen TK, Luthy DA, et al. A prospective study of maternal serum C-reactive protein (CRP) concentrations and risk of gestational diabetes mellitus. Paediatr Perinat Epidemiol. 2004;18(5):377–384.
4. Edalat B, Sharifi F, Badamchizadeh Z, et al. Association of metabolic syndrome with inflammatory mediators in women with previous gestational diabetes mellitus. J Diabetes Metab Disord. 2013;12(1):8.
5. Kim SY, Sy V, Araki T, et al. Total adiponectin, but not inflammatory markers C-reactive protein, tumor necrosis factor-alpha, interluekin-6 and monocyte chemoattractant protein-1, correlates with increasing glucose intolerance in pregnant Chinese. J Diabetes. 2014;6(4):360–368.
6. Jafarnejad S, Saremi S, Jafarnejad F, et al. Effects of a multispecies probiotic mixture on glycemic control and inflammatory status in women with gestational diabetes: a randomized controlled clinical trial. J Nutr Metab. 2016;2016:5190846.
7. Herrera E, Ortega-Senovilla H. Disturbances in lipid metabolism in diabetic pregnancy – Are these the cause of the problem? Best Pract Res Clin Endocrinol Metab. 2010;24(4):515–525.
8. Wilson RL, Grieger JA, Bianco-Miotto T, et al. Association between maternal zinc status, dietary zinc intake and pregnancy complications: a systematic review. Nutrients. 2016;8(10).
9. Grissa O, Atègbo JM, Yessoufou A, et al. Antioxidant status and circulating lipids are altered in human gestational diabetes and macrosomia. Transl Res. 2007;150(3):164–171.
10. Zima T, Fialová L, Mestek O, et al. Oxidative stress, metabolism of ethanol and alcohol-related diseases. J Biomed Sci. 2001;8(1):59–70.
11. Islam MR, Arslan I, Attia J, et al. Is serum zinc level associated with prediabetes and diabetes?: a cross-sectional study from Bangladesh. PLoS One. 2013;8(4):e61776.
12. Heidarzadeh Z, Samimi M, Seifati SM, et al. The effect of zinc supplementation on expressed levels of peroxisome proliferator-activated receptor gamma and glucose transporter type 1 genes in newborns of women with gestational diabetes mellitus. Biol Trace Elem Res. 2017;175(2):271–277.
13. Karamali M, Heidarzadeh Z, Seifati SM, et al. Zinc supplementation and the effects on metabolic status in gestational diabetes: a randomized, double-blind, placebo-controlled trial. J Diabetes Complications. 2015;29(8):1314–1319.
14. Capdor J, Foster M, Petocz P, et al. Zinc and glycemic control: a meta-analysis of randomised placebo controlled supplementation trials in humans. J Trace Elem Med Biol. 2013;27(2):137–142.
15. Jayawardena R, Ranasinghe P, Galappatthy P, et al. Effects of zinc supplementation on diabetes mellitus: a systematic review and meta-analysis. Diabetol Metab Syndr. 2012;4(1):13.
16. Mispireta ML, Caulfield LE, Zavaleta N, et al. Effect of maternal zinc supplementation on the cardiometabolic profile of Peruvian children: results from a randomized clinical trial. J Dev Orig Health Dis. 2017;8(1):56–64.
17. D’Adamo E, Marcovecchio ML, Giannini C, et al. Improved oxidative stress and cardio-metabolic status in obese prepubertal children with liver steatosis treated with lifestyle combined with vitamin E. Free Radic Res. 2013;47(3):146–153.
18. Wang Q, Sun Y, Ma A, et al. Effects of vitamin E on plasma lipid status and oxidative stress in Chinese women with metabolic syndrome. Int J Vitam Nutr Res. 2010;80(3):178–187.
19. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2014;37(Suppl 1):S81–S90.
20. Pisprasert V, Ingram KH, Lopez-Davila MF, et al. Limitations in the use of indices using glucose and insulin levels to predict insulin sensitivity: impact of race and gender and superiority of the indices derived from oral glucose tolerance test in African Americans. Diabetes Care. 2013;36(4):845–853.
21. Nobile de Santis MS, Radaelli T, Taricco E, et al. Excess of amniotic fluid: pathophysiology, correlated diseases and clinical management. Acta Biol Med. 2004;75(Suppl 1):53–55.
22. Dunkley PR, Jarvie PE, Robinson PJ. A rapid Percoll gradient procedure for preparation of synaptosomes. Nat Protoc. 2008;3(11):1718–1728.
23. Ranasinghe P, Wathurapatha WS, Galappatthy P, et al. Zinc supplementation in prediabetes: a randomized double-blind placebo-controlled clinical trial. J Diabetes. 2018;10(5):386–397.
24. Marreiro DN, Geloneze B, Tambascia MA, et al. Effect of zinc supplementation on serum leptin levels and insulin resistance of obese women. Biol Trace Elem Res. 2006;112(2):109–118.
25. Kelishadi R, Hashemipour M, Adeli K, et al. Effect of zinc supplementation on markers of insulin resistance, oxidative stress, and inflammation among prepubescent children with metabolic syndrome. Metab Syndr Relat Disord. 2010;8(6):505–510.
26. Chaves S, Jelic R, Mendonça C, et al. Complexes of hydroxy(thio)pyrone and hydroxy(thio)pyridinone with Zn(II) and Mo(VI). Thermodynamic stability and insulin-mimetic activity. Metallomics. 2010;2(3):220–227.
27. Tang X, Shay NF. Zinc has an insulin-like effect on glucose transport mediated by phosphoinositol-3-kinase and Akt in 3T3-L1 fibroblasts and adipocytes. J Nutr. 2001;131(5):1414–1420.
28. Manzella D, Barbieri M, Ragno E, et al. Chronic administration of pharmacologic doses of vitamin E improves the cardiac autonomic nervous system in patients with type 2 diabetes. Am J Clin Nutr. 2001;73(6):1052–1057.
29. Park S, Choi SB. Effects of alpha-tocopherol supplementation and continuous subcutaneous insulin infusion on oxidative stress in Korean patients with type 2 diabetes. Am J Clin Nutr. 2002;75(4):728–733.
30. Rossing P, Cooper ME, Parving HH. Comparison of the effects of vitamins and/or mineral supplementation on glomerular and tubular dysfunction in type 2 diabetes. Diabetes Care. 2006;29(3):747–748; author reply 748.
31. Böni-Schnetzler M, Donath MY. How biologics targeting the IL-1 system are being considered for the treatment of type 2 diabetes. Br J Clin Pharmacol. 2013;76(2):263–268.
32. Su D, Coudriet GM, Hyun Kim D, et al. FoxO1 links insulin resistance to proinflammatory cytokine IL-1beta production in macrophages. Diabetes. 2009;58(11):2624–2633.
33. Ranasinghe P, Wathurapatha WS, Ishara MH, et al. Effects of zinc supplementation on serum lipids: a systematic review and meta-analysis. Nutr Metab (Lond). 2015;12:26.
34. Mafra D, Santos FR, Lobo JC, et al. Alpha-tocopherol supplementation decreases electronegative low-density lipoprotein concentration [LDL(-)] in haemodialysis patients. Nephrol Dial Transplant. 2009;24(5):1587–1592.
35. Seet RC, Lee CY, Lim EC, et al. Oral zinc supplementation does not improve oxidative stress or vascular function in patients with type 2 diabetes with normal zinc levels. Atherosclerosis. 2011;219(1):231–239.
36. Leonard SW, Joss JD, Mustacich DJ, et al. Effects of vitamin E on cholesterol levels of hypercholesterolemic patients receiving statins. Am J Health Syst Pharm. 2007;64(21):2257–2266.
37. Halcox JP, Deanfield JE. Beyond the laboratory: clinical implications for statin pleiotropy. Circulation. 2004;109(21 Suppl 1):II42–II48.
38. Vardi M, Levy AP. Is it time to screen for the haptoglobin genotype to assess the cardiovascular risk profile and vitamin E therapy responsiveness in patients with diabetes? Curr Diab Rep. 2012;12(3):274–279.
39. Ye H, Zhao Q, Huang Y, et al. Meta-analysis of low density lipoprotein receptor (LDLR) RS2228671 polymorphism and coronary heart disease. BioMed Res Int. 2014;2014:564940.
40. Vashum KP, McEvoy M, Shi Z, et al. Is dietary zinc protective for type 2 diabetes? Results from the Australian longitudinal study on women’s health. BMC Endocr Disord. 2013;13:40.
41. Rogalska J, Brzóska MM, Roszczenko A, et al. Enhanced zinc consumption prevents cadmium-induced alterations in lipid metabolism in male rats. Chem Biol Interact. 2009;177(2):142–152.
42. Petering HG, Murthy L, O’Flaherty E. Influence of dietary copper and zinc on rat lipid metabolism. J Agric Food Chem. 1977;25(5):1105–1109.
43. Campbell SE, Rudder B, Phillips RB, et al. Gamma-tocotrienol induces growth arrest through a novel pathway with TGFbeta2 in prostate cancer. Free Radic Biol Med. 2011;50(10):1344–1354.